TABLE III.
Sensitivity (%) | 95%CI | Specificity (%) | 95%CI | |
---|---|---|---|---|
Pathologist #1 (n = 334) | ||||
Any HPV vs. any HPV-related external genital lesiona | 92.3 | 88.1–96.5 | 15.6 | 10.3–21.0 |
HPV 6/11 vs. condylomab | 75.0 | 67.9–82.1 | 34.7 | 28.0–41.5 |
HPV 16/18 vs. Penile intraepithelial neoplasia I–IIIc | 63.6 | 35.2–92.1 | 96.3 | 94.2–98.4 |
HR-HPV vs. Penile intraepithelial neoplasia I–IIId | 81.8 | 59.0–100 | 87.9 | 84.4–91.5 |
LR-HPV vs. condylomae | 90.3 | 85.4–95.1 | 20.0 | 14.3–25.7 |
Pathologist #3 (n = 156) | ||||
Any HPV vs. any HPV-related external genital lesiona | 93.9 | 88.2–99.7 | 15.6 | 8.1–23.0 |
HPV 6/11 vs. condylomab | 78.7 | 68.4–89.0 | 34.7 | 25.2–44.3 |
HPV 16/18 vs. Penile intraepithelial neoplasia I–IIIc | 40.0 | 0.0–82.9 | 94.7 | 91.1–98.3 |
HR-HPV vs. Penile intraepithelial neoplasia I–IIId | 40.0 | 0.0–82.9 | 86.1 | 80.6–91.6 |
LR-HPV vs. condylomae | 93.4 | 87.2–99.7 | 19.0 | 11.1–26.8 |
All pathological diagnoses thought to be HPV-related (condyloma, penile intraepithelial neoplasia I, and penile intraepithelial neoplasia II/ III) and HPV genotyping results that included the presence of at least one of the 28 HPV genotypes included in the assay.
All pathological diagnoses thought to be HPV 6/11-related (condyloma) and HPV results that included either HPV 6 or 11, or both.
All pathological diagnoses thought to be HPV 16/18-related (penile intraepithelial neoplasia I, and penile intraepithelial neoplasia II/III) and HPV results that included either HPV 16 or 18, or both.
All pathological diagnoses thought to be related to HR-HPV infection (penile intraepithelial neoplasia I and penile intraepithelial neoplasia II/III) and HPV results that included the presence of at least one of the HR-HPV genotypes included in the assay.
All pathological diagnoses thought to be related to LR-HPV infections (condyloma) and HPV results that included the presence of at least one of the LR-HPV genotypes included in the assay.